Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is -4.92% lower on its value in year-to-date trading and has touched a low of $0.62 and a high of $2.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXRX stock was last observed hovering at around $0.71 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.70, the stock is -8.12% and -9.58% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.92 million and changing -1.10% at the moment leaves the stock -50.68% off its SMA200. LXRX registered -73.50% loss for a year compared to 6-month loss of -58.20%..
The stock witnessed a -20.67% gain in the last 1 month and extending the period to 3 months gives it a -20.29%, and is -10.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.01% over the week and 11.75% over the month.
Lexicon Pharmaceuticals Inc (LXRX) has around 285 employees, a market worth around $253.84M and $5.23M in sales. Profit margin for the company is -4109.41%. Distance from 52-week low is 13.19% and -75.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.91%).
with sales reaching $6.48M over the same period.The EPS is expected to grow by 14.05% this year, but quarterly earnings will post 824.52% year-over-year. Quarterly sales are estimated to grow 822.99% in year-over-year returns.
Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders
The shares outstanding are 361.49M, and float is at 179.90M with Short Float at 23.92%.
The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 56.3318% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $64.99 million to account for 15.7656 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 4.0304% and valued at over $16.62 million, while VANGUARD GROUP INC holds 3.1277 of the shares totaling 7.68 million with a market value of $12.89 million.
Lexicon Pharmaceuticals Inc (LXRX) Insider Activity
#####
